GB9409565D0 - Microballs including a pharmaceutically active ingredient and a polymer - Google Patents

Microballs including a pharmaceutically active ingredient and a polymer

Info

Publication number
GB9409565D0
GB9409565D0 GB9409565A GB9409565A GB9409565D0 GB 9409565 D0 GB9409565 D0 GB 9409565D0 GB 9409565 A GB9409565 A GB 9409565A GB 9409565 A GB9409565 A GB 9409565A GB 9409565 D0 GB9409565 D0 GB 9409565D0
Authority
GB
United Kingdom
Prior art keywords
microballs
polymer
active ingredient
pharmaceutically active
pharmaceutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9409565A
Other versions
GB2277915B (en
GB2277915A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Publication of GB9409565D0 publication Critical patent/GB9409565D0/en
Publication of GB2277915A publication Critical patent/GB2277915A/en
Application granted granted Critical
Publication of GB2277915B publication Critical patent/GB2277915B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
GB9409565A 1993-05-15 1994-05-13 Microballs including a pharmaceutically active ingredient and a polymer Expired - Fee Related GB2277915B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939310030A GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same

Publications (3)

Publication Number Publication Date
GB9409565D0 true GB9409565D0 (en) 1994-07-06
GB2277915A GB2277915A (en) 1994-11-16
GB2277915B GB2277915B (en) 1997-10-29

Family

ID=10735537

Family Applications (2)

Application Number Title Priority Date Filing Date
GB939310030A Pending GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same
GB9409565A Expired - Fee Related GB2277915B (en) 1993-05-15 1994-05-13 Microballs including a pharmaceutically active ingredient and a polymer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB939310030A Pending GB9310030D0 (en) 1993-05-15 1993-05-15 Dry processed particles and process for the preparation of the same

Country Status (35)

Country Link
JP (1) JP3139913B2 (en)
KR (1) KR100341261B1 (en)
CN (1) CN1050534C (en)
AT (1) AT406017B (en)
AU (1) AU685094B2 (en)
BE (1) BE1008323A3 (en)
BR (1) BR9401968A (en)
CA (1) CA2123481C (en)
CH (1) CH688572A5 (en)
DE (1) DE4416812C2 (en)
DK (1) DK171454B1 (en)
DZ (1) DZ1779A1 (en)
ES (1) ES2097083B1 (en)
FI (1) FI112915B (en)
FR (1) FR2705232B1 (en)
GB (2) GB9310030D0 (en)
GR (1) GR1002034B (en)
HK (1) HK1002831A1 (en)
HU (1) HU220617B1 (en)
IE (1) IE940392A1 (en)
IN (1) IN182330B (en)
IT (1) IT1269508B (en)
LU (1) LU88482A1 (en)
MA (1) MA23194A1 (en)
NL (1) NL9400795A (en)
NO (1) NO307403B1 (en)
NZ (1) NZ260520A (en)
OA (1) OA09939A (en)
PL (1) PL175780B1 (en)
PT (1) PT101518B (en)
RU (1) RU2125869C1 (en)
SE (1) SE519004C2 (en)
SG (1) SG46631A1 (en)
TN (1) TNSN94046A1 (en)
ZA (1) ZA943316B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435055T2 (en) * 1993-01-06 2008-12-04 IPSEN Manufacturing Ireland Ltd., Blanchardstown Biodegradable polyesters for the preparation of ionic molecular conjugates with bioactive polypeptides
DK0678018T3 (en) * 1993-01-06 2003-04-28 Kinerton Ltd Ion Molecular Conjugates of Biodegradable Polyesters and Bioactive Polypeptides
DE19604744A1 (en) 1996-02-09 1997-08-14 Henkel Kgaa Technical di- / triglyceride mixtures
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
DE19617137C1 (en) * 1996-04-29 1997-02-27 Henkel Kgaa Use of branched alcohol ester(s) of olefin-di:carboxylic acid copolymers
US5858531A (en) * 1996-10-24 1999-01-12 Bio Syntech Method for preparation of polymer microparticles free of organic solvent traces
US6867181B1 (en) 1997-06-02 2005-03-15 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
ES2491866T3 (en) 1999-11-15 2014-09-08 Piramal Healthcare (Canada) Limited Temperature-controlled, pH-dependent, self-gelling aqueous biopolymer solution
KR100558119B1 (en) 2000-06-16 2006-03-10 가부시키가이샤 닛폰 쇼쿠바이 Crosslinked polymer, method for manufacturing it and use thereof
GB0705159D0 (en) * 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
CH672887A5 (en) * 1987-10-14 1990-01-15 Debiopharm Sa
WO1989003678A1 (en) * 1987-10-30 1989-05-05 Stolle Research & Development Corporation Low residual solvent microspheres and microencapsulation process
DE3916020C2 (en) * 1989-05-17 1994-06-01 Burkhard Dr Wichert Retarding microparticles made from biodegradable polyesters; Process for their preparation without the use of toxic solvents and pharmaceutical preparations containing these microparticles
KR0168849B1 (en) * 1990-04-12 1999-01-15 요시또시 가즈오 Coated composition and its preparation process
JP3116311B2 (en) * 1990-06-13 2000-12-11 エーザイ株式会社 Manufacturing method of microsphere
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
GB9016885D0 (en) * 1990-08-01 1990-09-12 Scras Sustained release pharmaceutical compositions
SE9003296L (en) * 1990-10-16 1992-04-17 Kabi Pharmacia Ab PROCEDURE SHOULD FORMULATE MEDICINAL PRODUCTS
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
SE467815B (en) * 1991-05-27 1992-09-21 Bengt Hjalmar Aagerup Med Firm METHOD FOR MAKING REPRODUCABLE PARTICLES OF DEFINED SIZE
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
JPH07507768A (en) * 1992-03-12 1995-08-31 アルカーメス コントロールド セラピューティクス,インコーポレイテッド Controlled release of ACTH-containing microspheres
SE9200858L (en) * 1992-03-20 1993-09-21 Kabi Pharmacia Ab Method for producing delayed release pellets
EP0644771B2 (en) * 1992-06-11 2006-12-06 Alkermes Controlled Therapeutics, Inc. Erythropoietin drug delivery system
US5350584A (en) * 1992-06-26 1994-09-27 Merck & Co., Inc. Spheronization process using charged resins
JP2651320B2 (en) * 1992-07-16 1997-09-10 田辺製薬株式会社 Method for producing sustained-release microsphere preparation
FR2693905B1 (en) * 1992-07-27 1994-09-02 Rhone Merieux Process for the preparation of microspheres for the sustained release of the hormone LHRH and its analogs, microspheres and formulations obtained.
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix

Also Published As

Publication number Publication date
PL175780B1 (en) 1999-02-26
IT1269508B (en) 1997-04-01
LU88482A1 (en) 1994-12-01
FR2705232A1 (en) 1994-11-25
IN182330B (en) 1999-03-20
CN1104557A (en) 1995-07-05
AU685094B2 (en) 1998-01-15
GB2277915B (en) 1997-10-29
AT406017B (en) 2000-01-25
HU9401412D0 (en) 1994-08-29
ATA98794A (en) 1999-06-15
GR1002034B (en) 1995-10-31
CA2123481A1 (en) 1994-11-16
JPH072652A (en) 1995-01-06
IE940392A1 (en) 1994-11-16
PT101518B (en) 2000-12-29
AU6308494A (en) 1994-11-17
KR100341261B1 (en) 2002-09-27
HU220617B1 (en) 2002-03-28
DK171454B1 (en) 1996-11-04
DZ1779A1 (en) 2002-02-17
HUT67599A (en) 1995-04-28
NO941810D0 (en) 1994-05-13
SG46631A1 (en) 1998-02-20
NO941810L (en) 1994-11-16
NZ260520A (en) 1994-12-22
CA2123481C (en) 2005-01-11
FR2705232B1 (en) 1995-08-25
SE9401557L (en) 1994-11-16
DE4416812C2 (en) 2003-02-06
GB9310030D0 (en) 1993-06-30
NL9400795A (en) 1994-12-01
SE9401557D0 (en) 1994-05-05
ES2097083B1 (en) 1997-12-01
TNSN94046A1 (en) 1995-04-25
SE519004C2 (en) 2002-12-17
CN1050534C (en) 2000-03-22
ZA943316B (en) 1995-01-16
BR9401968A (en) 1994-12-13
DK54994A (en) 1994-11-16
ITMI940931A1 (en) 1995-11-11
JP3139913B2 (en) 2001-03-05
FI942222A (en) 1994-11-16
OA09939A (en) 1994-11-15
NO307403B1 (en) 2000-04-03
BE1008323A3 (en) 1996-04-02
GB2277915A (en) 1994-11-16
MA23194A1 (en) 1994-12-31
HK1002831A1 (en) 1998-09-18
FI942222A0 (en) 1994-05-13
RU2125869C1 (en) 1999-02-10
PT101518A (en) 1995-03-01
DE4416812A1 (en) 1994-11-17
FI112915B (en) 2004-02-13
CH688572A5 (en) 1997-11-28
ITMI940931A0 (en) 1994-05-11
ES2097083A1 (en) 1997-03-16

Similar Documents

Publication Publication Date Title
GB9412938D0 (en) Pharmaceutically active antioxidants
ZA949378B (en) A medicinal aerosol formulation
HRP940351A2 (en) Aptically active 2-imidazolin-5-one and 2-imidazolin-5-thione derivatives and fungicides
IL111978A0 (en) Dry-compressed paroxetine formulations and their preparation
GB2277915B (en) Microballs including a pharmaceutically active ingredient and a polymer
NZ257470A (en) 5-hydrazino-quinolone derivatives and antimicrobial medicaments
AU5715594A (en) Polycationic polymer and polycationic bactericidal/algicidal agent
GB9309380D0 (en) Packaging and other constructions
GB2284602B (en) Pharmaceutically active diketopiperazines
IL124423A0 (en) Pharmaceutical composition comprising an active compound in a polymer
GB9220715D0 (en) Immunopotentiatory agent and physiologically acceptable salts thereof
AU4701993A (en) Pharmacologically active glycerophosphoderivatives
SG45240A1 (en) Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof
IL105261A0 (en) Hydroxamates and pharmaceutical compositions comprising them
ZA944633B (en) Pharmaceutically active antioxidants
GB9226874D0 (en) Immunopotentiatory agents and physiologically acceptable salts thereof
GB9305997D0 (en) Pharmaceutically active compounds
GB9306767D0 (en) Pharmaceutically active compounds
GB9326512D0 (en) Pharmaceutically active compounds
GB9310462D0 (en) Pharmaceutically active compounds
GB9319835D0 (en) Pharmaceutically active compounds
GB9300119D0 (en) Pharmaceutically active compounds
GB9325410D0 (en) Pharmaceutically active compounds
GB9323345D0 (en) Pharmaceutically active compounds
GB9323344D0 (en) Pharmaceutically active compounds

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20100513